EQRx, Inc.

EQRx, Inc. (Nasdaq: EQRX) is a biopharmaceutical company that went public in 2021 through a SPAC merger with CMLS Holdings Corp., a blank-check company that completed its initial public offering that year. Operating in the healthcare and life sciences sector, EQRx was built around a model of developing and commercializing innovative medicines at substantially reduced costs for patients and payers globally. The company filed an amended quarterly report, Form 10-Q/A, with the SEC on November 23, 2021, shortly after completing its public market debut via the SPAC transaction. Sign up at SpacDesk for full filing history, deal analytics, and company data on EQRx and the broader SPAC universe.